Oric Pharmaceuticals Inc (ORIC)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $779.47M
Last updated: Nov 17, 2026 at 4:40 PM ET
Oric Pharmaceuticals Inc (ORIC) Stock Chart
Oric Pharmaceuticals (ORIC) has a latest price of $8.00 on Nov 17, 2026, 45.5% below its 52-week high of $14.68. Its price fell 34.7% over the past 12 months. The month-end price fell 36.9% over the 5 years through Oct 2026, a compound annual decline of 8.8%.
Price Chart
From Apr 2020 to Oct 2026, its highest month-end close was $33.91 in Nov 2020 and its lowest $2.67 in Oct 2022, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart ORIC with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for ORIC.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 45.4%, and over 6 months it rose 0.4%. The month-end price rose 37.9% over the 3 years through Oct 2026, a compound annual rate of 11.3%.
| Period | Change |
|---|---|
| 1 month | -37.1% |
| 3 months | -45.4% |
| 6 months | +0.4% |
| 12 months | -34.7% |
| 12 months, with dividends | -34.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +37.9% | +11.3% |
| 5 years | -36.9% | -8.8% |
Price by Year
Its best calendar year was 2023, when the price rose 56.2%, and its weakest was 2022, when it fell 59.9%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $9.24 | +13.0% |
| 2025 | $8.18 | +1.4% |
| 2024 | $8.07 | -12.3% |
| 2023 | $9.20 | +56.2% |
| 2022 | $5.89 | -59.9% |
| 2021 | $14.70 | -56.6% |
Trading Range
The price is 29.6% below its 50-day average of $11.36 and 27.0% below its 200-day average of $10.97.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $8.00 | |
| 52-week high | $14.68 | -45.5% |
| 52-week low | $7.23 | +10.7% |
| 50-day average | $11.36 | -29.6% |
| 200-day average | $10.97 | -27.0% |
Price Risk
Over 3 years, its largest fall from a peak was 73.5%.
| Measure | Value |
|---|---|
| 1-year beta | 1.21 |
| Largest fall, 1 year | -48.7% |
| Largest fall, 3 years | -73.5% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About ORIC
What is ORIC's 1-year price change?
Oric Pharmaceuticals's price fell 34.7% over the past 12 months. With dividends included, the 12-month total return was -34.7%.
What is ORIC's 5-year price change?
Oric Pharmaceuticals's month-end price fell 36.9% over the 5 years through Oct 2026, a compound annual decline of 8.8%. These figures leave out dividends.
What is ORIC's 52-week high and low?
Oric Pharmaceuticals's 52-week high is $14.68 and its 52-week low is $7.23. Its latest price of $8.00 on Nov 17, 2026 is 45.5% below the high.
What is ORIC's beta?
Oric Pharmaceuticals's 1-year beta against the S&P 500 is 1.21, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 48.7%.
Is the ORIC chart free?
Yes. Advanced Charting for ORIC is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
ORIC pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors